[Official Co-organizer Announcement] Cytiva Co-hosts 2026BPD Singapore Biopharmaceutical Process Development Conference
2026BPDSingaporewill be9 22-23InMarina Bay Sands Singapore Convention & Exhibition CentreHosted by Yimao Medical and co-organized again by WuXi AppTec, the conference will invite 500+ Attendee50+Speaker, SetPlaceTechnical Forum、CEO Closed-Door Meeting、BPD NIGHT、1-on-1 MeetingWaitMulti-dimensional focus on manufacturing capacity cooperation, market access, and regional compliance in Southeast Asia. We bridge Chinese pharmaceutical companies and suppliers with local partners to capitalize on the strategic window for expansion into Southeast Asia.
Cytiva confirms as co-organizer in Singapore for 2026BPDand will be deeply involvedBPD Plenary Forum: High-Level Interview、Closed-door meeting、BPD & XDC Gala Dinner、BPD Match 1v1 AppointmentMulti-stakeholder collaboration, continuously driving regional innovation synergy and industrial ecosystem co-construction!
About Cytiva 2026 BPD
Cytiva is a global life sciences leader that partners with academic and translational researchers, developers, and manufacturers of biotherapeutics, cell and gene therapies, and emerging technologies like mRNA to enable the delivery of transformative medicines. With nearly 16,000 associates across 40 countries, Cytiva is a trusted expert dedicated to accelerating customers' speed, flexibility, capacity, and efficiency in drug discovery, research, and manufacturing. Visitcytiva.comfor more.
Forum & Closed-door Meeting Participation 2026 BPD Singapore
As a key player in global life sciences and bioprocessing solutions,CytivaJoinBPD Plenary Forum: In-depth Interviews and Executive RoundtableAddressing core challenges of Chinese biopharmaceuticals going global amid global supply chain restructuring, this session focuses on bilateral collaborative development pathways between China and Southeast Asia's industrial ecosystems, featuring dialogues with multiple industry leaders.
[9/22 - Session 1]
BPD Plenary Forum
09:40–10:20 Panel Discussion:Cross-Border Synergy and Bilateral Co-Development: China's Global Expansion and the Southeast Asian Industrial Ecosystem Amid Global Supply Chain Restructuring
Moderator:Jimmy Li, WuXi XDC, CEO
Panelist:Bo Ying, CEO, Abogen Biosciences
Aimin Hui, EnCureGen Pharma, Founder, Chairman & CEO
Xiaoliang Sang, Cytiva, Vice President
Gang Qin, GeneQuantum, CEO
[9/22-Session 3]
Closed-door meeting
China–Southeast Asia Cross-Border Biopharma Collaboration
Moderator: Jimmy Li, CEO, WuXi XDC
15:00-15:30 Guest Representative Presentations:National Biopharma Industry Ecosystems
Speaker:
Jimmy Li, WuXi XDC, CEO
Teo Junxiong, HSA, Director of Partnerships and Ecosystem Development
Koh Boon Tong, Bioprocessing Technology Institute (BTI), Executive Director
PengfeiChen, EDB, VP
Billy Urudra, MOPI, Executive Director
Shanti Marlina Sibuea, Badan POM, Act. Director
15:30-16:30 Discussion:Exploring Cross-Border Cooperation Models
Open Discussion
Reference Discussion Topics
What cooperation models are available? What is the most critical factor when selecting partners?
How to balance policy frameworks and industrial ecosystems when selecting overseas expansion locations?